To the Editor: Fenofibrate (TRICOR) as a third-generation fibric acid derivative indicated for dyslipidemia. ALT elevations have been reported in 19% of patients receiving fenofibrate, exceeding three times the upper limit of normal in 5.3% (1, 2). Although these elevations usually normalize 2– 4 weeks after discontinuation of the medication (3), rare cases… (More)
DOI: 10.1007/s10620-005-1600-6


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics